为体外动脉粥样硬化研究设计稳健的二维和三维球体模型的关键参数

IF 6.1 2区 医学 Q1 ENGINEERING, BIOMEDICAL
Ibukunoluwa Naiyeju, Stephanie Lehoux, Maryam Tabrizian
{"title":"为体外动脉粥样硬化研究设计稳健的二维和三维球体模型的关键参数","authors":"Ibukunoluwa Naiyeju, Stephanie Lehoux, Maryam Tabrizian","doi":"10.1002/btm2.10736","DOIUrl":null,"url":null,"abstract":"Atherosclerosis is a chronic, systemic, inflammatory disease associated with the build‐up of fatty deposits (“plaques”) in the arteries. A major global health burden, severe atherosclerosis progresses to ischemic heart disease, an underlying condition which can exacerbate the occurrence of fatal events such as heart attack and stroke. Over the past two decades, the use of <jats:italic>in vitro</jats:italic> models to study atherosclerotic phenomena has increased, with the goal of complementing clinical research for drug and therapy development. In particular, 2D co‐culture models, and in the last decade, 3D spheroid models have been developed to improve our understanding of the atherosclerotic disease mechanism. However, the existing literature lacks information on the relevant parameters which should be considered prior and during the design of these models to promote model robustness and enhance their biomimetic capacities. This review provides an overview of such key parameters, as well as future perspectives on how existing limitations in the field of cell‐based <jats:italic>in</jats:italic> <jats:italic>vitro</jats:italic> model design can be improved. It is expected that by carefully considering these parameters, researchers will be better equipped with the required knowledge to develop biomedically and clinically relevant <jats:italic>in vitro</jats:italic> models.","PeriodicalId":9263,"journal":{"name":"Bioengineering & Translational Medicine","volume":"20 1","pages":""},"PeriodicalIF":6.1000,"publicationDate":"2025-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Key parameters for designing robust 2D and 3D spheroid models for in vitro atherosclerosis research\",\"authors\":\"Ibukunoluwa Naiyeju, Stephanie Lehoux, Maryam Tabrizian\",\"doi\":\"10.1002/btm2.10736\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Atherosclerosis is a chronic, systemic, inflammatory disease associated with the build‐up of fatty deposits (“plaques”) in the arteries. A major global health burden, severe atherosclerosis progresses to ischemic heart disease, an underlying condition which can exacerbate the occurrence of fatal events such as heart attack and stroke. Over the past two decades, the use of <jats:italic>in vitro</jats:italic> models to study atherosclerotic phenomena has increased, with the goal of complementing clinical research for drug and therapy development. In particular, 2D co‐culture models, and in the last decade, 3D spheroid models have been developed to improve our understanding of the atherosclerotic disease mechanism. However, the existing literature lacks information on the relevant parameters which should be considered prior and during the design of these models to promote model robustness and enhance their biomimetic capacities. This review provides an overview of such key parameters, as well as future perspectives on how existing limitations in the field of cell‐based <jats:italic>in</jats:italic> <jats:italic>vitro</jats:italic> model design can be improved. It is expected that by carefully considering these parameters, researchers will be better equipped with the required knowledge to develop biomedically and clinically relevant <jats:italic>in vitro</jats:italic> models.\",\"PeriodicalId\":9263,\"journal\":{\"name\":\"Bioengineering & Translational Medicine\",\"volume\":\"20 1\",\"pages\":\"\"},\"PeriodicalIF\":6.1000,\"publicationDate\":\"2025-03-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bioengineering & Translational Medicine\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.1002/btm2.10736\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering & Translational Medicine","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1002/btm2.10736","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

摘要

动脉粥样硬化是一种慢性、全身性、炎症性疾病,与动脉中脂肪沉积(“斑块”)的积累有关。严重动脉粥样硬化是全球主要的健康负担,可发展为缺血性心脏病,这是一种可能加剧心脏病发作和中风等致命事件发生的潜在疾病。在过去的二十年中,体外模型研究动脉粥样硬化现象的使用有所增加,目的是补充药物和治疗开发的临床研究。特别是2D共培养模型,在过去的十年中,3D球体模型已经被开发出来,以提高我们对动脉粥样硬化疾病机制的理解。然而,现有文献缺乏在这些模型设计之前和设计过程中应该考虑的相关参数的信息,以提高模型的鲁棒性和增强其仿生能力。这篇综述提供了这些关键参数的概述,以及如何改进基于细胞的体外模型设计领域现有限制的未来观点。期望通过仔细考虑这些参数,研究人员将更好地配备所需的知识来开发生物医学和临床相关的体外模型。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Key parameters for designing robust 2D and 3D spheroid models for in vitro atherosclerosis research
Atherosclerosis is a chronic, systemic, inflammatory disease associated with the build‐up of fatty deposits (“plaques”) in the arteries. A major global health burden, severe atherosclerosis progresses to ischemic heart disease, an underlying condition which can exacerbate the occurrence of fatal events such as heart attack and stroke. Over the past two decades, the use of in vitro models to study atherosclerotic phenomena has increased, with the goal of complementing clinical research for drug and therapy development. In particular, 2D co‐culture models, and in the last decade, 3D spheroid models have been developed to improve our understanding of the atherosclerotic disease mechanism. However, the existing literature lacks information on the relevant parameters which should be considered prior and during the design of these models to promote model robustness and enhance their biomimetic capacities. This review provides an overview of such key parameters, as well as future perspectives on how existing limitations in the field of cell‐based in vitro model design can be improved. It is expected that by carefully considering these parameters, researchers will be better equipped with the required knowledge to develop biomedically and clinically relevant in vitro models.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Bioengineering & Translational Medicine
Bioengineering & Translational Medicine Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
8.40
自引率
4.10%
发文量
150
审稿时长
12 weeks
期刊介绍: Bioengineering & Translational Medicine, an official, peer-reviewed online open-access journal of the American Institute of Chemical Engineers (AIChE) and the Society for Biological Engineering (SBE), focuses on how chemical and biological engineering approaches drive innovative technologies and solutions that impact clinical practice and commercial healthcare products.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信